TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 44 filers reported holding TARSUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,876,530 | +49.5% | 105,601 | +52.0% | 0.00% | – |
| Q2 2023 | $1,255,178 | +227287.3% | 69,462 | +58.3% | 0.00% | – |
| Q1 2023 | $552 | -23.2% | 43,880 | -10.6% | 0.00% | – |
| Q4 2022 | $719 | -99.9% | 49,065 | -13.9% | 0.00% | – |
| Q3 2022 | $976,000 | +13.2% | 57,018 | -3.5% | 0.00% | – |
| Q2 2022 | $862,000 | +126.2% | 59,070 | +171.4% | 0.00% | – |
| Q1 2022 | $381,000 | -32.6% | 21,763 | 0.0% | 0.00% | – |
| Q4 2021 | $565,000 | +13.9% | 21,763 | 0.0% | 0.00% | – |
| Q3 2021 | $496,000 | -33.4% | 21,763 | -15.4% | 0.00% | – |
| Q2 2021 | $745,000 | +55.9% | 25,723 | +73.4% | 0.00% | – |
| Q1 2021 | $478,000 | +14.6% | 14,832 | +47.0% | 0.00% | – |
| Q4 2020 | $417,000 | – | 10,088 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |